This live blog session has ended. Stay tuned to MoneyControl for more updates.
Coronavirus Highlights: India recorded less than 50,000 new coronavirus infections, the lowest in 91 days, taking the total tally of cases to 2,99,77,861, while active cases fell below 7 lakh after 79 days, according to the Union Health Ministry data updated on Tuesday. A total of 42,640 Covid infections were reported in a day, while the death toll climbed to 3,89,302 with 1,167 daily fatalities, the lowest in 68 days. According to the data published at 7 am, India administered 86.16 lakh vaccine doses, the highest ever single-day vaccination achieved in the world so far, the Health Ministry said. Cumulatively, 28.87 crore vaccine doses have been administered so far under the nationwide inoculation drive. The active cases have further declined to 6,62,521, comprising 2.21 per cent of the total infections, while the national COVID-19 recovery rate has improved to 96.49 per cent, the data updated at 8 am showed. A net decline of 40,366 cases has been recorded in the caseload in a span of 24 hours. Also, 16,64,360 tests were conducted on Monday, taking the total cumulative tests conducted so far for detection of COVID-19 in the country to 39,40,72,142, while the daily positivity rate has declined to 2.56 per cent. It has been less than 5 per cent for 15 consecutive days, the ministry said. The weekly positivity rate has declined to 3.21 per cent.

This live blog session has ended. Stay tuned to MoneyControl for more updates.
| Tamil Nadu reports 6,895 new cases, 13,156 recoveries, and 194 deaths in past 24 hours.
Active cases: 56,886
Total recoveries: 23,48,353
Death toll: 31,580
| Punjab reports 409 new cases, 880 discharges, and 20 deaths in the past 24 hours.
Active cases: 5,968
Total discharges: 5,71,207
Death toll: 15,888
Vaccination will not happen in Maharashtra's Pimpri Chinchwad tomorrow as workers of vaccination centres will be given weekly off, says Pimpri Chinchwad Municipal Corporation.
| Maharashtra reports 8,470 new cases, 9,043 recoveries and 1188 deaths in 24 hours.
Recovery Rate: 95.9%
Case Fatality Rate: 1.98%
Positivity Rate: 15.01%
| Telangana reports 1,175 new #COVID cases, 1,771 recoveries and 10 death in 24 hours.
Active cases: 16,640
Total recoveries: 5,95,348
Death toll: 3,586
|5.52 lakh people vaccinated against COVID-19 in Maharashtra today: State Health Department
Eleven people who received the AstraZeneca-Oxford COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies.While seven cases were reported from a medical centre in Kerala, where about 1.2 million people were administered the AstraZeneca COVID-19 vaccine, known as Covishield in India, four were reported from Nottingham, UK, in an area in which approximately 700,000 (7 lakh) people received the jab.All 11 had received the Covid preventive 10-22 days earlier.
Mumbai reported 570 new coronavirus infections and 10 fatalities on Tuesday, the Brihanmumbai Municipal Corporation (BMC) said. With this, the tally of cases rose to 7,22,461 and death toll increased to 15,315, it said. On Monday, the financial capital of the country had recorded 521 new cases and seven deaths. There are 14,453 active COVID-19 cases in the city. With 742 patients discharged from hospitals during the day, the total of recovered patients rose to 6,90,417. So far 68,73,621 COVID-19 tests have been conducted in the city including 32,307 in the last 24 hours. The rate of recovery in the city is 95 per cent, while the average growth rate of cases between June 15 and June 21 was 0.9 per cent. The period during which the caseload doubled was 722 days, as per the BMC update. Mumbai currently has 11 containment zones in slums and chawls besides 86 sealed buildings. The city had reported its highest 11,163 COVID-19 cases on April 4 while the highest 90 deaths were recorded on May 1, during the second wave.
Twenty-two cases of the Delta plus variant of the coronavirus have been detected in India, with 16 of them being reported from Maharashtra and the remaining from Madhya Pradesh and Kerala, the government said on Tuesday.India is among the nine countries where the Delta plus mutation has been found so far, Union Health Secretary Rajesh Bhushan said at a press briefing, underlining that it is currently a 'variant of interest' and has not yet been classified as a 'variant of concern'.Besides India, the Delta plus variant has been found in the US, UK, Portugal, Switzerland, Japan, Poland, Nepal, China and Russia. The Delta variant has been detected in 80 countries, he said.Cases of the Delta plus variant have been detected in Maharashtra's Ratnagiri and Jalgaon and parts of Kerala and Madhya Pradesh.'Any variant's transmissibility and virulence decides whether it is a variant of concern or interest. Delta variant is found in 80 countries around the world, including India and it is a variant of concern. 'Delta plus variant has been detected in nine countries including India. In India, 22 cases of Delta Plus variant have been found and it is in the category of variant of interest, (and) yet not a variant of concern,' Bhushan said.He said the Health Ministry has released an advisory on the kind of public health response that Maharashtra, MP and Kerala should initiate to address this issue which 'presently looks fairly small in terms of number but we would not want this to assume significant proportions'.He further said that INSACOG has 28 laboratories and they have sequenced 45,000 samples, of which 22 cases of delta plus variant have been found.'The labs of INSACOG bring this information to the notice of Health Ministry which then in timely and prompt manner indicates to the concerned states what are the activities that have to be initiated to curb the spread. The public health response is standardised for the variants,' he said.INSACOG, or Indian SARS-CoV-2 Consortium on Genomics, was set up to conduct genome sequencing of the coronavirus.
Pfizer CEO Albert Bourla on June 22 said the US-based drug maker is final stages to sign an agreement with Indian government to supply COVID-19 vaccines."We are discussing with India govt, we are in final stages of finalising agreement," Bourla said at the 15th annual BioPharma & Healthcare Summit, USA-India Chamber of Commerce (USAIC).
States Chief Secretaries have been advised to take up immediate containment measures in the dists & clusters (as identified by INSACOG) incl preventing crowds& intermingling of people, widespread testing, prompt tracing as well as vaccine coverage on priority basis.